MedTrace Logo

Relationship Between Topiramate Use and Ocular Angle Status

NCT00153699 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2007-10-31

No results posted yet for this study

Summary

We test the hypothesis whether topiramate narrows the angles which may render Asians more likely to suffer from acute angle closure glaucoma.

Conditions

  • Glaucoma, Angle-Closure

Interventions

DRUG

Topiramate

Sponsors & Collaborators

  • Hong Kong Eye Hospital

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Dexter YL Leung, MRCS · Hong Kong Eye Hospital

  • Howan Leung, MRCP · Chinese University of Hong Kong

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Completion
2007-07-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00153699 on ClinicalTrials.gov